Have you wondered how some of the leading pharmaceutical and biopharmaceutical manufacturers have developed and tested their COVID-19 vaccine candidates in record time? In a Pharma Manufacturing article, The new requirement to fast-track vaccines, Emerson group president for the Systems and Software business, Jim Nyquist, shares ways in which these feats were accomplished.
Emerson’s Michalle Adkins will be discussing villains and heroes in knowledge management at the fully digital November 2-6, 2020 ISPE Annual Meeting and Expo.
The whitepaper, How to Simplify Your Pneumatic Valve Installation to Improve Your Drug Manufacturing Operation, highlights the critical role that pneumatic valve systems play across the drug development lifecycle—from drug discovery and production, to packaging and utilities.
Emerson’s Michalle Adkins and Ron Rossbach will host a webinar on reducing time to market for new therapies—a key opportunity for pharmaceutical and biopharmaceutical manufacturers. This webinar will take place on August 13 at 15:00 CET – Europe / 09:00 EDT.
For pharmaceutical and biopharmaceutical manufacturers, the Life Sciences.NOW webinar series includes eight interactive discussions on digital plant technologies and will provide direction and updates on key manufacturing operation initiatives to improve operational performance, deliver cost effective quality and regulatory compliance and accelerate the product development pipeline.
In a May 19 BioPharma Asia webinar, Continuous Manufacturing as a Default Platform for Oral Solid Drug Products, Emerson’s Bob Lenich will team up with Johnson and Johnson Senior Principal Engineer Lawrence De Belder to discuss the path to continuous manufacturing for these types of medicines.
Pharma 4.0 is an initiative based on Industry 4.0, begun out of the International Society for Pharmaceutical Engineering Germany/Austria/Switzerland (ISPE D/A/CH) organization, which lead to the formation of: …the ISPE Pharma 4.0 special interest group (SIG) in 2017....
Suppliers to the industry have been innovating to meet the single-use requirements of biotech manufacturers. Emerson’s Michalle Adkins pointed me to a recent award received for technology innovation for these single-use requirements.
Digital twins provide a simulation of the manufacturing or production process as well as the automation systems which control it. Depending on the level of fidelity of the process models, this digital twin can have many uses. I caught up with Emerson's Zuwei Jin who...
For pharmaceutical and biopharmaceutical manufacturers, scaling up production has typically meant large, 5000+ liter stainless steel bioreactors for the process. These require cleaning and sterilization between batches. Market demands are driving the need for more...
The Interphex conference for pharmaceutical and biotech manufacturers is underway this week in New York City. Emerson's Bob Lenich is presenting Big Data in Life Sciences Manufacturing. Bob opens citing one pharmaceutical manufacturer who generates 5000 data points...
The U.S. Food & Drug Administration (FDA) outlines the drug development process in five steps: Discovery and development Preclinical research Clinical trials FDA review FDA post-market safety monitoring I caught up with Emerson's Zuwei Jin whom you may recall from...
Stay up to Date with the Latest News and Updates
Subscribe for Updates
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to keep up to date on all the latest news, events and innovations to help you take on and solve your toughest challenges.
Our Global Community